HanAll Biopharma hanall.co.kr

HanAll Biopharma (KRX: 009420) focuses on the research and development of biopharmaceuticals that can be a source of hope for patients with rare and incurable diseases who are suffering from no proper treatment. HanAll Biopharma is researching and developing new antibody drugs with mechanism of action, which is capable of treating various rare autoimmune diseases that occur due to autoantibodies; an anti-TNF bio pharmaceutical, which is developed for inflammatory eye diseases such as dry eye dis...Show all

HanAll Biopharma (KRX: 009420) focuses on the research and development of biopharmaceuticals that can be a source of hope for patients with rare and incurable diseases who are suffering from no proper treatment. HanAll Biopharma is researching and de...Show all

Company (IPO / Went public)

All investors data 0 Investors